GoAI
Get started
BioDlink International Company Limited logo

BioDlink International Company Limited

1875.HK

HKSEHealthcareBiotechnology

Open in GoAI

Latest quote

HK$3.96

−HK$0.06 · -1.49%

Aug 24, 4:08 PM HKT

1875.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

BioDlink International Co., Ltd. operates as a clinical-stage biopharmaceutical firm, dedicating its resources to the development and future commercialization of novel oncology drugs and therapeutic solutions. Its pipeline features several key product candidates, including TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009, and its primary base of operations is situated in Suzhou, China.

Industry
Biotechnology
Sector
Healthcare
Headquarters
CN
CEO
Shan Fu
Listed since
Nov 8, 2019
Employees
596

Market position

Day range

Current HK$3.96

52-week range

Current HK$3.96

Open
HK$4.085
Previous close
HK$4.02
Volume
1.47M
1.29× average
Average volume
1.14M
Average daily volume
Market cap
2.87B HKD
Beta
-0.13
Market reference 1
50-day average
HK$3.4994
+13.16% above average
200-day average
HK$3.6491
+8.52% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.68B CNY
P/E (TTM)
-25.26×
P/B (TTM)
3.93×
P/S (TTM)
3.29×
EV / EBITDA
-261.56×
Earnings yield
-6.16%
Free cash flow yield
-1.65%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
52.03%
Operating margin
-12.13%
Net margin
-13.42%
Return on equity
-16.03%
Return on assets
-7.97%
Return on invested capital
-8.71%

Financial health

Debt / equity
0.61×
Current ratio
2.05×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends126%-44%-214%-385%Gross margin, FY2021: 36.00%Gross margin, FY2022: 83.82%Gross margin, FY2023: 73.53%Gross margin, FY2024: 71.24%Gross margin, FY2025: 52.03%Operating margin, FY2021: -340.26%Operating margin, FY2022: -8.84%Operating margin, FY2023: -4.24%Operating margin, FY2024: 3.76%Operating margin, FY2025: -12.13%Net margin, FY2021: -342.24%Net margin, FY2022: -11.29%Net margin, FY2023: -4.84%Net margin, FY2024: 3.16%Net margin, FY2025: -13.42%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 36.00%. Gross margin FY2022 83.82%. Gross margin FY2023 73.53%. Gross margin FY2024 71.24%. Gross margin FY2025 52.03%. Operating margin FY2021 -340.26%. Operating margin FY2022 -8.84%. Operating margin FY2023 -4.24%. Operating margin FY2024 3.76%. Operating margin FY2025 -12.13%. Net margin FY2021 -342.24%. Net margin FY2022 -11.29%. Net margin FY2023 -4.84%. Net margin FY2024 3.16%. Net margin FY2025 -13.42%.

Income trends

Revenue

747.65M CNY-31.93%

Operating income

−90.69M CNY−131.95M CNY

Net income

−100.37M CNY−135.13M CNY
Income trends across reported periods1.23B CNY690.47M CNY146.65M CNY−397.17M CNYRevenue, FY2021: 76.33M CNYRevenue, FY2022: 442.18M CNYRevenue, FY2023: 780.63M CNYRevenue, FY2024: 1.1B CNYRevenue, FY2025: 747.65M CNYOperating income, FY2021: −259.7M CNYOperating income, FY2022: −39.08M CNYOperating income, FY2023: −33.06M CNYOperating income, FY2024: 41.25M CNYOperating income, FY2025: −90.69M CNYNet income, FY2021: −261.22M CNYNet income, FY2022: −49.92M CNYNet income, FY2023: −37.76M CNYNet income, FY2024: 34.76M CNYNet income, FY2025: −100.37M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 76.33M CNY. Revenue FY2022 442.18M CNY. Revenue FY2023 780.63M CNY. Revenue FY2024 1.1B CNY. Revenue FY2025 747.65M CNY. Operating income FY2021 −259.7M CNY. Operating income FY2022 −39.08M CNY. Operating income FY2023 −33.06M CNY. Operating income FY2024 41.25M CNY. Operating income FY2025 −90.69M CNY. Net income FY2021 −261.22M CNY. Net income FY2022 −49.92M CNY. Net income FY2023 −37.76M CNY. Net income FY2024 34.76M CNY. Net income FY2025 −100.37M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue747.65M CNY1.1B CNY780.63M CNY442.18M CNY76.33M CNY
Cost of goods sold358.67M CNY315.9M CNY206.64M CNY71.56M CNY48.85M CNY
Gross profit388.98M CNY782.43M CNY573.99M CNY370.62M CNY27.47M CNY
Research and development85.68M CNY79.31M CNY103.89M CNY151.17M CNY214.7M CNY
Selling, general, and administrative401.58M CNY688.09M CNY509.33M CNY266.54M CNY79.19M CNY
Operating expenses479.67M CNY741.18M CNY607.05M CNY409.45M CNY287.17M CNY
Interest income2.25M CNY3.38M CNY2.97M CNY2.27M CNY969K CNY
Interest expense11.92M CNY9.88M CNY5.18M CNY6.6M CNY2.47M CNY
Depreciation and amortization74.05M CNY38.8M CNY43.03M CNY38.04M CNY34.24M CNY
Operating income−90.69M CNY41.25M CNY−33.06M CNY−39.08M CNY−259.7M CNY
Net income−100.37M CNY34.76M CNY−37.76M CNY−49.92M CNY−261.22M CNY

Company facts updated Aug 24, 2026.

Continue in GoAI

Research 1875.HK

research.disclaimer